摘要 : Surgical resection of localized gastrointestinal stromal tumors (GISTs) is associated with recurrence rates of approximately 50% at 5 years of follow-up. The introduction of tyrosine kinase inhibitors, such as imatinib, improved o... 展开
作者 | Bednarski~B.K. Pisters~P.W. Hunt~K.K. |
---|---|
作者单位 | |
期刊名称 | 《Expert review of anticancer therapy》 |
总页数 | 10 |
语种/中图分类号 | 英语 / R73 |
关键词 | gastrointestinal stromal tumors GIST imatinib neoadjuvant surgical resection |
馆藏号 | N2007EPST0001717 |